Study on the effects of statin on growth and differentiation of cartilage

他汀类药物对软骨生长和分化影响的研究

基本信息

  • 批准号:
    13671938
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

Statin compounds are reported to activate BMP-2 gene expression and to generate the bone formation as a result. Statins are originally known to be inhibitors for HMG CoA reductase that strongly lower plasma cholesterol and triglycerides levels in human and animals and are used for the therapy of hypercholesterolemia. In this study, stains, serivastatin and pravastatin are examined for their action on growth and differentiation of cartilage.Several cDNA probes are generated from human and rabbit to examine the differentiation markers. Using these porbes, the effects of statins on primary cultures of chondrocytes and stem cells from rabbits were determined and following results were obtained.Pravastatin increased the Jevel of BMP-2 mRNA in rabbit chondrocytes for 24 h at 10^<-5> M.Serivastatin did not affect the level of BMP-2 mRNA in rabbit stem cells at 10^<-6> M, whereas it markedly increased the level of Indian hedgehog mRNA concomitantly increment of levels of PTHrP and alkaline phosphatase mRNA was observed. Calcification was observed at 5x10^<-5> M.In the course of this study, novel basic helix-loop-helix transcription factors, DEC1 and DEC2, were isolated and proved to be involved in the regulation of chondrocyte differentiation. DEC1 and DEC2 were ubiquitously expressed in various organs and exhibit multiple functions including new members of molecular clock regulation circadian rhythm of animals. The rhythmic expression of DEC1 and DEC2 were also observed in cartilage indicating the importance of rhythmic regulation of chondrocyte growth and differentiation.
据报道,他汀类化合物可激活BMP-2基因表达并因此产生骨形成。他汀类药物最初已知是HMG CoA还原酶的抑制剂,其强烈降低人和动物的血浆胆固醇和甘油三酯水平,并用于治疗高胆固醇血症。本研究以人和兔软骨为材料,制备了几种cDNA探针,检测了它们对软骨生长和分化的影响。结果表明:普伐他汀在10 μ M浓度下作用24 h后,可增加兔软骨细胞BMP-2 mRNA的表达,而西伐<-5>他汀在10 μ M浓度下对兔干细胞BMP-2 mRNA的表达无影响<-6>,但可显著增加兔干细胞Indian hedgehog mRNA的表达,同时可增加PTHrP和碱性磷酸酶mRNA的表达。在5 × 104 μ M时观察到钙化<-5>。在本研究过程中,分离出新型碱性螺旋-环-螺旋转录因子DEC 1和DEC 2,并证明其参与软骨细胞分化的调节。DEC 1和DEC 2广泛表达于多种器官,具有多种功能,包括调节动物昼夜节律的分子钟新成员。DEC 1和DEC 2的节律性表达也在软骨中观察到,表明软骨细胞生长和分化的节律性调节的重要性。

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshida, E. et al.: "Direct Inhibition of Indian Hedgehog Expression by PTH/PTH-Related Peptide and Up-Regulation by Retinoic Acidin Growth Plate Chondrocyte Cultures"Exp. Cell Res.. 265. 64-72 (2001)
Yoshida, E. 等人:“PTH/PTH 相关肽对 Indian Hedgehog 表达的直接抑制以及视黄酸生长板软骨细胞培养物的上调”实验。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kim, HG et al.: "Hypocholesteromic effect of bile acid sulfonate analogs in the hamsters"Biol. Pharm. Bull. 24. 218-220 (2001)
Kim, HG 等人:“胆汁酸磺酸盐类似物对仓鼠的低胆固醇作用”Biol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ming Shen, Takeshi Kawamoto, Masao Teramoto, Seicho Makihira, Katsumi Fujimoto, Mitsuhide Noshiro, Yukio Kato: "Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway"Eur.J.Cell Bi
Ming Shen、Takeshi Kawamoto、Masao Teramoto、Seicho Makihira、Katsumi Fujimoto、Mitsuhide Noshiro、Yukio Kato:“诱导碱性螺旋-环-螺旋蛋白 DEC1 (BHLHB2)/Stra13/Sharp2 响应环磷酸腺苷途径”Eur。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Katsumi Fujimoto, Ming Shen, Mitsuhide Noshiro^*, Kazumi Matsubara, Sohei Shingu, Kiyomasa Honda, Eri Yoshida, Ketut Suardita, Yoichi Matsuda, and Yukio Kato: "Molecular Cloning and Characterization of DEC2, a New Member of Basic Helix-Loop-Helix Proteins
Katsumi Fujimoto、Ming Shen、Mitsuhide Noshiro^*、Kazumi Matsubara、Sohei Shingu、Kiyomasa Honda、Eri Yoshida、Ketut Suardita、Yoichi Matsuda 和 Yukio Kato:“基本螺旋环新成员 DEC2 的分子克隆和表征
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujimoto, K. et al.: "Molecular Cloning and Characterization of DEC2, a New Member of Basic Helix-Loop-Helix Proteins"Biochem. Biophys. Res. Commun.. 260. 164-171 (2001)
Fujimoto, K. 等人:“基本螺旋-环-螺旋蛋白新成员 DEC2 的分子克隆和表征”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NOSHIRO Mitsuhide其他文献

NOSHIRO Mitsuhide的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NOSHIRO Mitsuhide', 18)}}的其他基金

Study on the roles of DEC1 and DEC2 in the rhythmic regulation of lipid metabolism.
DEC1和DEC2在脂质代谢节律调节中的作用研究
  • 批准号:
    22590223
  • 财政年份:
    2010
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulatory mechanism of rhythmic expression of cholesterol metabolizing enzymes by clock-related gene DEC1 and DEC2
时钟相关基因DEC1和DEC2对胆固醇代谢酶节律表达的调控机制
  • 批准号:
    19590226
  • 财政年份:
    2007
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation and function of retinol binding protein in cartilage
软骨中视黄醇结合蛋白的调节和功能
  • 批准号:
    11671842
  • 财政年份:
    1999
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Expression and function of RGD-CAP conatining RGD-motif in cartilage
含有RGD基序的RGD-CAP在软骨中的表达和功能
  • 批准号:
    09671894
  • 财政年份:
    1997
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

statin对Alzheimer病早期病变的干预和机制研究
  • 批准号:
    30800350
  • 批准年份:
    2008
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Understanding the impact of type 1 diabetes and statin use on vascular cells
了解 1 型糖尿病和他汀类药物的使用对血管细胞的影响
  • 批准号:
    MR/Y001028/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Research Grant
頚動脈プラークに対するスタチンはプラークを安定させるかーNIRSによる分布の変化
他汀类药物治疗颈动脉斑块可以稳定斑块的 NIRS 分布变化吗?
  • 批准号:
    23K15652
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of novel combination therapy of chimeric antigen receptor T cells and HMG-CoA reductase inhibitors (statin)
嵌合抗原受体T细胞和HMG-CoA还原酶抑制剂(他汀类药物)的新型联合疗法的开发
  • 批准号:
    23K15306
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Coronary plaque changes with statin and colchicine among people with high polygenic risk- a mechanistic pilot study
他汀类药物和秋水仙碱对高多基因风险人群的冠状动脉斑块变化——一项机制试点研究
  • 批准号:
    10736120
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Data-Driven Discovery of Heterogeneous Treatment Effects of Statin Use on Dementia Risk
他汀类药物使用对痴呆风险的异质治疗效果的数据驱动发现
  • 批准号:
    10678219
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Suicide risk modification by statin prescriptions in US Veterans with common inflammation-mediated clinical conditions- a controlled, quasi-randomized epidemiological approach
通过他汀类药物处方降低患有常见炎症介导临床病症的美国退伍军人的自杀风险——一种受控、准随机的流行病学方法
  • 批准号:
    10487844
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Midlife statin use and late life cognition
中年他汀类药物的使用和晚年认知
  • 批准号:
    10523563
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
Optimization of statin regimens for atherosclerotic cardiovascular disease prevention using polygenic risk scores and real-world evidence
使用多基因风险评分和真实世界证据优化他汀类药物预防动脉粥样硬化性心血管疾病的方案
  • 批准号:
    10683792
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
Improving Adherence with Statins Through Use of the Statin Choice Decision Aid
通过使用他汀类药物选择决策辅助工具提高他汀类药物的依从性
  • 批准号:
    10683788
  • 财政年份:
    2022
  • 资助金额:
    $ 1.92万
  • 项目类别:
Development, testing, and implementation of virtual statin associated muscle symptom (SAMS) management
虚拟他汀类药物相关肌肉症状 (SAMS) 管理的开发、测试和实施
  • 批准号:
    10184656
  • 财政年份:
    2021
  • 资助金额:
    $ 1.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了